Bolt Biotherapeutics, Inc. is a biotechnology company currently conducting clinical trials, focused on developing innovative immuno-oncology therapies.
52W Range
17thpctl
Volume
0.99×avg
Market Cap
7.33MUSD
P/E Ratio
-0.2TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Bolt Biotherapeutics, Inc.
BOLTNASDAQ Global Select·USD·Closed
Bolt Biotherapeutics, Inc.
BOLTNASDAQ·USD·Closed
$3.81
−4.62%
$3.81
−$0.18 (4.62%)
52W Range
17thpctl
Volume
0.99×avg
Mkt Cap
7.33MUSD
P/E
-0.2TTM
Div Yield
–ann
BOLT: Bolt Biotherapeutics, Inc. Stock Analysis | finqOS
